Navigation Links
14% Of Pune Population Diabetic: Children Most Affected

A new US based study titled 'Search for Diabetes in Youth' has highlighted the alarming rate of incidence of juvenile diabetes //. It further points out to the importance of keeping a constant vigil on the sugar level, which is the only way to prevent the associated complications. The results of the study have been published in the spring 2006 issue of Countdown, an official journal of the Juvenile Diabetes Research Foundation.

In another similar Pune based study, conducted by the Diabetes Care and Research Foundation reveals that diabetes is prevalent in 14% of the Pune population. Even more alarming is the fact that majority of these are children, who suffer from Type 1 diabetes.

Diabetes Mellitus sets in when the body loses its ability to convert the glucose into energy. This is characterized by an elevation in the blood glucose level. In insulin dependent diabetes, also referred to as Type 1 diabetes, the insulin producing cells of the pancreas get destroyed. As a consequence, there is a severe lack of insulin. Such people are dependent on insulin injections to enable glucose metabolism. A strict adherence to the prescribed diabetic diet prevent further rising of the blood glucose level.

Type 2 diabetes is also called as non-insulin dependent diabetes. In this condition, although some amount of insulin is being produced, this quantity is insufficient to meet the demand.

The problem associated with diabetes, which is rightly called the slow poison, is that if left unattended, it can lead to a number of diabetic complications, increasing an individual’s susceptibility to heart disease, stroke, kidney damage, eye disease and amputations. The only sure way to prevent these complications is to perform regular blood glucose check ups remarked Dr. Abhay Mutha, Director, Diabetes Care and Research Foundation.

The foundation has been helping diabetic children through adoption and provision of appropriate diabetic car
'"/>




Page: 1 2

Related medicine news :

1. Poor health care in Russia maybe causing Decline in its Population
2. Prime Minister Manmohan Against Incentive-Based Population Control
3. Pigs Population A Major Threat To Encephalitis Ravaged UP
4. Scorecard to help in diabetic risk assessment of the Indian Population
5. Scorecard to help in diabetic risk assessment of the Indian Population
6. Elderly Population’s Sedentary Lifestyle Is Dependant On Their Expectations From Lif
7. Rural Population Enjoys Better Mental Health
8. Prevention And Control Of Diabetes Crucial To Indian Population
9. Inclination of North Carolina’s Elderly Population towards Home Remedie
10. Swaziland And Lesotho Sees Sharp Increase In AIDS/HIV Population
11. Bihar And Uttar Pradesh Must Take Initiative In Population Control
Post Your Comments:
(Date:12/2/2008)... , SAN DIEGO, Dec. 2 Strolle...owing exercise program for new moms and their babi...aby care for more than 40 years, has signed on as ... The new partnership will strengthen the companies...d moms. , , "We are thrilled to have Pamper...
(Date:12/2/2008)...omized Comparator Study to Evaluate Efficacy of Co... , WOODCLIFF LAKE, N.J., Dec. 2 ...d that it plans to initiate the first clinical tri...ne for injection) compared to Vidaza(R) (azacitidi...diate-2 or high-risk myelodysplastic syndromes (MD...
(Date:12/2/2008)...VILLE, Tenn., Dec. 2 Emdeon, a lea...ment solutions for the healthcare industry,annou...nitor business,efficiency in healthcare. Emdeon u...( www.ushealthcareindex.com ) to establish a natio...sition from a paper-based and phone-based,system ...
(Date:12/2/2008)...ERS, Ind., Dec. 2 A number of rece...in childhood obesity, the health risks in,overwei...ue of cereals and,other foods kids consume. Yet ...fers all natural, freeze-dried real fruit products...ut also provide most, if not all, of the daily fru...
Breaking Medicine News(10 mins):Health News:Stroller Strides(R) Signs Pampers(R) as Premier Sponsor for 2009 2Health News:Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes 2Health News:Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes 3Health News:Emdeon Convenes Industry Forum to Monitor Business Efficiency in Healthcare 2Health News:Emdeon Convenes Industry Forum to Monitor Business Efficiency in Healthcare 3Health News:Emdeon Convenes Industry Forum to Monitor Business Efficiency in Healthcare 4Health News:Moms Find Fun, Healthy Snacks That Help Fight Childhood Obesity 2Health News:Moms Find Fun, Healthy Snacks That Help Fight Childhood Obesity 3
...shington University verified the health benefits o...o assess the potential of both categories in the m...l levels and weight loss.// The study was conduct...ere half the group was asked to follow a low fat v...
...rating condition of a leprosy centre in the capita... for either relocation or reconstruction of the fa...undation and goodwill ambassador of World Health O...hen he visited the Satya Jeevan Kushta Ashram on J...
... of New Zealand is making certain changes to asthm...e changes are bound to benefit// a significant num...of the changes include widening the access to asth...easing the choice available to patients by introdu...
...l, West Sussex was prosecuted for intentionally in...as issued to arrest him.// He failed to appear a...h Crown Court that the 47-year-old businessman wou...ing a lengthy jail sentence for inflicting bodily ...
Other Medicine News:
(Date:12/1/2008)...re/ -- New research has found that the availabilit...T) scanner in an emergency room can significantly ...a potentially life-saving treatment. Results of th...NSMC)-Salem Hospital in Salem, Mass., will be pres...cal Society of North America (RSNA). , , "T...
(Date:12/1/2008)...BIO Pte Ltd today announced the initiation of a Ph...lly-active JAK2 inhibitor, in leading medical cent...hic myelofibrosis (CIMF). , , The trial is...of SB1518 in patients with CIMF and is expected to... study will assess the safety profile and evaluate...
(Date:12/1/2008)...olicy , , ROCHESTER, Minn., Dec. 1 /PRNews...inds the use of the drug therapy etanercept ineffe...flammation of the liver caused by excessive consum...lished in the December issue of Gastroenterology ...DEO ALERT: Additional audio and video resources, i...
(Date:12/1/2008)...l/ -- GeoVax Labs, Inc.,(OTC Bulletin Board: GOVX...ng,human vaccines for diseases caused by HIV-1 (H... agents, announced today that the launch of its Ph...elve sites across North and South America.,These ...ional Institutes of,Health (NIH), and the HIV Vac...
Breaking Medicine Technology:Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 2S*BIO Advances JAK2 Inhibitor SB1518 into Phase 1/2 Clinical Trial in Australia for the Treatment of Chronic Idiopathic Myelofibrosis 3Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 2GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America 3BioCryst to Release Third Quarter 2007 Financial Results on Thursday November 8 2007 5597 1BioCryst to Release Third Quarter 2007 Financial Results on Thursday November 8 2007 5597 2BioCryst to Release Third Quarter 2007 Financial Results on Thursday November 8 2007 5597 3BioCryst to Release Third Quarter 2007 Financial Results on Thursday November 8 2007 5597 4Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange 5595 1Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange 5595 2Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange 5595 3Emageon Reports Third Quarter 2007 Financial Results 5593 1Emageon Reports Third Quarter 2007 Financial Results 5593 2Emageon Reports Third Quarter 2007 Financial Results 5593 3Emageon Reports Third Quarter 2007 Financial Results 5593 4Emageon Reports Third Quarter 2007 Financial Results 5593 5Emageon Reports Third Quarter 2007 Financial Results 5593 6Emageon Reports Third Quarter 2007 Financial Results 5593 7Emageon Reports Third Quarter 2007 Financial Results 5593 8Emageon Reports Third Quarter 2007 Financial Results 5593 9Sanofi Pasteur Presents Positive Results of Tetravalent Dengue Candidate Vaccine 5591 1Sanofi Pasteur Presents Positive Results of Tetravalent Dengue Candidate Vaccine 5591 2Sanofi Pasteur Presents Positive Results of Tetravalent Dengue Candidate Vaccine 5591 3Sanofi Pasteur Presents Positive Results of Tetravalent Dengue Candidate Vaccine 5591 4
...dest, Most Comprehensive Survey Provides New Bench... June 21, 2007 /PRNewswire-USNewswire/ -- The,foll... -- First nationwide study of the prevalence of ...s (MRSA), a virulent multi-drug resistant organism...MRSA prevalence study findings significantly excee...
... LEE, N.J.--(BUSINESS WIRE)--Jun 21, 2007 - Neurol...ation in the June 23 issue,of the journal The Lanc...erapy trial for Parkinson,s disease and the first ...n brain cells for any adult,neurodegenerative dise...2 patients with,advanced Parkinson,s disease demon...
Other Medicine Technology:Nationwide MRSA Prevalence Study to Demonstrate Full Scope of,'Superbug' Threat Facing U.S. Healthcare Facilities and Patients 2Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 2Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 3Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 4Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 5Neurologix Announces Publication of Landmark Gene Therapy Study,Demonstrating Safety and Statistically Significant Improvement in,Patients With Advanced Parkinson's Disease 6
Indicated for treatment of patella instability
OmoTrain is a unique support for the shoulder that promotes mobility and limits rotation.
... someone suffers an episode of acute low back pain...ickly restores functional mobility by providing po...,With just a few sizes that correspond directly to... will reduce inventory requirements while simplify...
Shoulder Immobilizer with Body Strap Navy blue cotton. Thumb look helps keep hand in neutral position. Padded, 2" blue pile material laminated to foam shoulder and body strap. Fits left or right. 5/p
Medicine Products: